Radial vs. Focused Shockwave Therapy: Which Is Better? | Novo Soft Tissue

"Radial" and "focused" shockwave aren't two brand names for the same thing — they're two different physical mechanisms, and recent research makes it clear that neither one is simply the "upgraded" version of the other. Which one performs better depends heavily on what's actually being treated, and in a fair number of well-designed studies, it barely matters at all. Here's what the evidence from the last few years actually shows, condition by condition, rather than the marketing-driven version of this comparison.

Two different waves, two different physics

Focused ESWT (fESWT) generates a pressure wave that converges to a specific point at a set depth — like a magnifying glass concentrating sunlight to a focal point. It delivers high energy precisely, and how deep that focal point sits can be adjusted. Radial ESWT (rESWT) works the opposite way: a projectile strikes an applicator and the energy radiates outward from the skin surface, spreading over a broader area but losing intensity quickly with depth. It's technically not even a true "shockwave" — it's a radial pressure wave — though the name has stuck.

That single physical difference — a concentrated point at depth versus a dispersed pattern at the surface — is what determines almost everything else in this comparison: which conditions respond better to which device, and why the answer sometimes comes back "it doesn't matter."

When focused wins: deep, precisely localized tissue

A 2026 systematic review and meta-analysis pooling 9 randomized trials and 530 patients with upper and lower limb tendinopathy found that, used as a standalone treatment, focused ESWT produced a statistically significant edge in pain reduction over radial (standardized mean difference of 0.49, p = 0.006), with that advantage more pronounced at mid-term follow-up. The authors were careful to note this was based on lower-quality evidence and that, once therapies were combined with other treatments, the pain difference between modalities disappeared — but the standalone finding tracks with the physics: a tendon injury that sits at a specific, identifiable depth is exactly the kind of target focused energy is built to reach.

That depth-dependent pattern shows up outside orthopedics, too. A separate review of shock wave devices for chronic pelvic pain found focused generators produced a consistent, statistically significant benefit across trials (essentially zero variability between studies), while radial devices produced wildly inconsistent results that didn't reach significance. The researchers' explanation was the mechanism itself: "focused systems create a focal zone with deeper tissue penetration... radial devices disperse energy more superficially." When the structure being treated is genuinely buried beneath more superficial tissue, that difference in reach stops being theoretical.

When radial wins: broader targets and, in at least one condition, the long run

Radial doesn't just serve as a cheaper stand-in for focused. In one of the largest recent analyses on tennis elbow (lateral epicondylitis) — a network meta-analysis spanning 23 trials and 1,484 patients — radial ESWT ranked far above focused for long-term disability scores (a statistical ranking measure called SUCRA put radial at 92.9 versus focused's 19.9) and for pain at rest at long-term follow-up. Focused only pulled ahead for short-term grip strength. The 2026 tendinopathy review referenced above found something similar in isolation: radial produced significantly better wrist extensor strength recovery than focused in tennis elbow patients (p < 0.001), even though grip strength itself didn't differ between the two.

The likely explanation is, again, the physics matched to the anatomy: the common extensor tendon origin at the elbow is a broad, superficial attachment site, not a single deep focal point, and a wave designed to disperse energy over an area may simply suit that anatomy better than one designed to concentrate it at depth.

It's worth being honest that a second, more recent network meta-analysis on the same condition found a messier picture — medium-intensity radial best for short-term pain, low-intensity focused best for long-term pain, and low-intensity radial best for function scores. Different meta-analyses, different trial mixes, not fully agreeing with each other. That's a genuinely accurate reflection of where this specific research question stands right now, not a reason to ignore either study.

When it genuinely doesn't matter

For a real share of common conditions, well-designed head-to-head trials have found no meaningful difference at all. A 2024 trial of 112 plantar fasciitis patients split between radial and focused treatment, each run for three weeks, found both produced significant pain and function improvement from baseline with no statistically significant difference between them at any point, including long-term follow-up. A 2025 sham-controlled trial of upper trapezius myofascial trigger points found the same thing: radial and focused produced statistically identical pain improvement at every time point measured, and both clearly outperformed sham treatment. The researchers' own read was telling — focused theoretically offers better, adjustable-depth penetration, but a superficial trigger point doesn't need that theoretical advantage, so it didn't translate into a real-world edge. A well-known earlier trial on patellar tendinopathy reached the same "no difference" conclusion as well.

The pattern across all of these: when the target tissue sits close enough to the surface that both wave types can reach it adequately, the choice of device stops being the variable that matters.

When combining both outperforms either alone

For Achilles tendinopathy that hadn't responded to exercise therapy, a retrospective study comparing radial alone (58 patients) to combined radial-plus-focused treatment (29 patients) found something worth paying attention to: the average improvement in functional scores wasn't statistically different between groups, but the proportion of patients who reached a clinically meaningful improvement was — 89.7% in the combined group versus 63.8% with radial alone (p = .022). In plain terms, combining the two didn't necessarily make the average patient improve dramatically more, but it made a genuinely meaningful result far more reliable and predictable across the group as a whole. For a condition like Achilles tendinopathy, where superficial paratenon irritation and deeper tendon substance changes can both be part of the problem, treating both depths in the same course of care appears to close a gap that either wave type alone sometimes leaves open.

What this means for your treatment plan

There's no single "better" shockwave device — there's a better match for the specific tissue, depth, and condition in front of us, and the research increasingly backs that up rather than crowning one modality as universally superior. That's the same reasoning behind why we don't run every patient through an identical combination of tools: a superficial trigger point, a deep tendon injury, and a chronic case with both a surface and depth component are three different physics problems, even when they show up as the same complaint of "shoulder pain" or "heel pain."

If you've wondered why your treatment plan uses one type of shockwave over another — or whether combining approaches might close the gap on a stubborn injury — request an appointment and we'll walk through exactly what the exam tells us about which tool, or combination of tools, actually fits your case, the same way we approach breaking down adhesion as one piece of a larger plan rather than a one-size-fits-all fix.